Diabetes Metab Syndr Obes. 2010 Sep 09;3:311-7. doi: 10.2147/DMSOTT.S10744.
Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome.
Diabetes, metabolic syndrome and obesity : targets and therapy
Fuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, Jairo E Rivera, Scarlet Baez, Marcel E Lechin
Affiliations
Affiliations
- Department of Pathophysiology, Sections of Neuroendocrinology, Neuropharmacology, and Neurochemistry, Instituto de Medicina Experimental, Faculty of Medicine, Universidad Central de Venezuela, Caracas.
PMID: 21437100
PMCID: PMC3047992 DOI: 10.2147/DMSOTT.S10744
Abstract
OBJECTIVE: The aim of our study was to determine the central and peripheral autonomic nervous system profiles underlying anorexia nervosa (AN) syndrome, given that affected patients present with the opposite clinical profile to that seen in the hyperinsulinism syndrome.
DESIGN: We measured blood pressure and heart rate, as well as circulating neurotransmitters (noradrenaline, adrenaline, dopamine, plasma serotonin, and platelet serotonin), using high-performance liquid chromatography with electrochemical detection, during supine resting, one minute of orthostasis, and after five minutes of exercise. In total, 22 AN patients (12 binge-eating/purging type and 10 restricting type) and age-, gender-, and race-matched controls (70 ± 10.1% versus 98 ± 3.0% of ideal body weight) were recruited.
RESULTS: We found that patients with AN had adrenal sympathetic overactivity and neural sympathetic underactivity, demonstrated by a predominance of circulating adrenaline over noradrenaline levels, not only during the supine resting state (52 ± 2 versus 29 ± 1 pg/mL) but also during orthostasis (67 ± 3 versus 32 ± 2 pg/mL, P < 0.05) and after exercise challenge (84 ± 4 versus 30 ± 3 pg/mL, P < 0.01).
CONCLUSION: Considering that this peripheral autonomic nervous system disorder depends on the absolute predominance of adrenomedullary C1 adrenergic nuclei over A5 noradrenergic pontine nucleus, let us ratify the abovementioned findings. The AN syndrome depends on the predominance of overwhelming adrenal sympathetic activity over neural sympathetic activity. This combined central and autonomic nervous system profile contrasts with that registered in patients affected by hyperinsulinism, hypoglycemia, and bulimia syndrome which depends on the absolute predominance of neural sympathetic activity.
Keywords: adrenal sympathetic activity; adrenaline; anorexia nervosa; eating disorders; noradrenaline
References
- Psychoneuroendocrinology. 1987;12(2):117-29 - PubMed
- J Comp Neurol. 1987 Jul 22;261(4):529-42 - PubMed
- Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jun;30(4):565-85 - PubMed
- Eur J Pharmacol. 1989 Dec 12;174(1):127-30 - PubMed
- Trends Pharmacol Sci. 2000 Nov;21(11):425 - PubMed
- J Neural Transm (Vienna). 1998;105(6-7):561-73 - PubMed
- Can J Physiol Pharmacol. 1982 Dec;60(12):1464-74 - PubMed
- Neurosci Lett. 2002 Oct 31;332(2):107-10 - PubMed
- Diabetes Metab Syndr Obes. 2009 Dec 02;2:203-13 - PubMed
- J Hypertens. 2007 Jan;25(1):147-55 - PubMed
- Biol Psychiatry. 1989 Mar 15;25(6):799-802 - PubMed
- Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):214-22 - PubMed
- Clin Sci (Lond). 1991 Apr;80(4):373-84 - PubMed
- Expert Opin Investig Drugs. 1998 Nov;7(11):1781-93 - PubMed
- Am J Hypertens. 1989 Dec;2(12 Pt 2):363S-374S - PubMed
- Neuropsychobiology. 1992;26(1-2):4-11 - PubMed
- J Pharmacol Sci. 2005 Sep;99(1):52-60 - PubMed
- Exp Clin Endocrinol Diabetes. 2000;108(6):389-95 - PubMed
- Expert Opin Investig Drugs. 1999 May;8(5):575-84 - PubMed
- J Neural Transm (Vienna). 2001;108(7):793-801 - PubMed
- Psychosom Med. 1979 Dec;41(8):661-72 - PubMed
- J Comp Neurol. 1996 Jan 15;364(3):402-413 - PubMed
- Diabetologia. 1983 Nov;25(5):377-81 - PubMed
- Biol Psychiatry. 1981 Oct;16(10):969-86 - PubMed
- Clin Exp Hypertens. 1993 Jan;15(1):209-40 - PubMed
- J Comp Neurol. 1992 Mar 22;317(4):379-95 - PubMed
- J Clin Endocrinol Metab. 1985 Dec;61(6):1053-60 - PubMed
- J Clin Endocrinol Metab. 1983 Nov;57(5):911-4 - PubMed
- Pharmacol Rev. 2000 Dec;52(4):595-638 - PubMed
- J Neural Transm (Vienna). 2010 Mar;117(3):293-9 - PubMed
- Brain Res. 1989 Jul 3;491(1):156-62 - PubMed
- Neuroscience. 2005;132(4):991-1007 - PubMed
- Diabetes. 2005 May;54(5):1447-51 - PubMed
- J Auton Nerv Syst. 1988 Aug;23(2):161-74 - PubMed
- Clin Sci (Lond). 2008 May;114(9):589-90 - PubMed
- Biol Psychiatry. 1995 Aug 1;38(3):166-73 - PubMed
- Am J Physiol. 1994 Mar;266(3 Pt 2):H1075-86 - PubMed
- Br J Pharmacol. 1989 Aug;97(4):1067-74 - PubMed
- Neuroendocrinology. 1985 Aug;41(2):156-62 - PubMed
- Gut. 1993 Feb;34(2):166-72 - PubMed
- Acta Physiol Lat Am. 1975;25(4):339-46 - PubMed
- J Neurosci. 1990 Jul;10(7):2139-47 - PubMed
- Dig Dis Sci. 2009 Mar;54(3):458-70 - PubMed
- Neuroendocrinology. 2006;84(4):222-34 - PubMed
- Dig Dis Sci. 1990 Nov;35(11):1313-9 - PubMed
- Brain Res. 1999 Jan 9;815(2):227-36 - PubMed
- Physiol Rev. 1994 Apr;74(2):323-64 - PubMed
- Brain Res. 1989 Jul 10;491(2):274-96 - PubMed
- Brain Res. 1994 Feb 28;638(1-2):248-60 - PubMed
- Eksp Klin Farmakol. 2005 Jan-Feb;68(1):36-8 - PubMed
- J Comp Neurol. 1989 Dec 22;290(4):561-84 - PubMed
Publication Types